Table .

Clinical Outcomes

Outcome	Value at 1 y	Value at 2 y
Medication use*
Oral anticoagulation	6.5	7.1
Dual‐antiplatelet therapy	5.9	6.2
Aspirin alone	96.9	95.3
Safety†
All‐cause mortality	6.4 (25)	9.3 (36)
Cardiovascular or unknown mortality	4.2 (16)	5.5 (21)
All stroke	2.9 (11)	3.4 (13)
Ischemic stroke	2.9 (11)	3.1 (12)
Hemorrhagic stroke	0 (0)	0.3 (1)
Systemic embolism	0.3 (1)	0.3 (1)
Major bleeding	8.2 (32)	10.1 (39)
BARC 3	7.7 (30)	9.6 (37)
BARC 5	0.5 (2)	0.5 (2)
Pericardial effusion requiring intervention‡	1.0 (4)	1.0 (4)
Requiring open cardiac surgery	0 (0)	0 (0)
Requiring pericardiocentesis or pericardial puncture	1.0 (4)	1.0 (4)
Device embolization	0 (0)	0 (0)

BARC indicates Bleeding Academic Research Consortium.

^*Values are percentage of patients who reported being on that medication at the time of visit. Patients may have been on >1 medication, so values may not total to 100%.

^† Values are Kaplan‐Meier cumulative estimates of clinical events committee–adjudicated outcomes, expressed as percentage (number).

^‡ Pericardial effusion requiring either open surgery or pericardiocentesis.